Search

everythinglearnresearchcommunity

for

Search:↓

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The optimized microemulsion with cinnamon oil effectively delivers finasteride through the skin without damaging hair.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Finasteride may cause long-lasting sexual side effects.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Finasteride shows promise for female hair loss, but more research needed.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Exosomes from skin cells can boost hair growth by stimulating a gene called LEF1.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The review explains how hair products work and the science of different hair types to help improve hair care research.

The skin systems of jawed vertebrates evolved diverse appendages like hair and scales from a common structure over 420 million years ago.

A new tool can analyze hair to detect changes due to hormones, genetics, and aging.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Modified stem cells from umbilical cord blood can make hair grow faster.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.